Speaker illustration

Ms Desiree Loikas

Karolinska Institute, Stockholm (Sweden)

Increased thromboprophylactic treatment of patients with atrial fibrillation after the introduction of NOACs - an analysis of sex and gender differences

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention

Thumbnail

This platform is supported by

logo Novo Nordisk